Clinical Trials Logo

Clinical Trial Summary

This study aimed investigate the chronic effect of orange juice consumption on gut microbiota and in the bioavailability of flavanones and metabolites by feces, blood and urine analysis.


Clinical Trial Description

Non-randomized study with interrupted time series and open-label, in which women were enrolled and advised to not consumed foods containing prebiotic, probiotic and fibers, and citrus fruits and beverages during 30 days before of intervention (n=10; BMI 23.8 kg/m2; 28 years). After 30 days, the participants will consume during 60 days 300 mL of orange juice daily. After 60 days of orange juice intervention, the participants will be submitted to 30 days of washout. Samples of blood, urine and feces will collect in five different occasions (baseline, 30 day, 60 day, 90 day, and 120 day) in order to evaluate the prebiotic effect of orange juice on gut microbiota and in the bioavailability of its flavanones. The recruitment process began in September 2016 and the intervention was carried out from October 2016 to February 2017, and the data analysis will start in February 2017. The sample number took into account variances on blood hesperitin levels with a type I error α = 0.05 and a type II error β = 0.2 (80% power) (Silveira et al., 2015). The minimum sample size should have six individuals into the same group. Considering an approximately 15% dropout rate, the final sample size of study was constituted by 10 women. Primary endpoint is the changes in total bacteria population (Lactobacillus spp., Bifidobacterium spp., and reduction of Clostridium spp.) that can result in increased of butyric, acetic, and propionic acid concentrations, and reduction of ammonium production. Secondary endpoint is enhancement of bioavailability of flavanones (hesperitin, naringenin) and metabolites in the blood, urine and feces. Kolmogorov Smirnov and Levene test will be used to assess the normality and homogeneity of data, respectively. One-way analysis of variance (ANOVA) will be apply to determine the intervention effect over the time 0, 30 day, 60 day, 90 day, and 120 day). P significance was set up ≤ 0.05. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03032861
Study type Interventional
Source São Paulo State University
Contact
Status Completed
Phase N/A
Start date September 2016
Completion date February 2017

See also
  Status Clinical Trial Phase
Recruiting NCT02295254 - Microbiome Changes in Travelers to Tropical Destinations N/A
Completed NCT02246647 - Biomarkers for Intestinal Permeability in Patients With Constipation
Recruiting NCT05322486 - Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Active, not recruiting NCT01037049 - Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks Phase 2
Completed NCT01872286 - Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2 N/A
Completed NCT04080843 - Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients Phase 2
Terminated NCT04644315 - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors Phase 2
Completed NCT02445365 - Remote Ischemic Conditioning in Patients With Ulcerative Colitis N/A
Recruiting NCT04949282 - Spanish Series of Patients Treated With the Radionuclide Lutetium177
Active, not recruiting NCT01995942 - Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial
Completed NCT02647866 - Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis Phase 2
Completed NCT02693782 - Fabulous Fibre Study - Effect of Wheat Bran Extract on Gut and General Health in Healthy Aging Subjects (FFS) N/A
Completed NCT02831556 - Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Not yet recruiting NCT02806206 - Prucalopride Prior to Small Bowel Capsule Endoscopy Phase 4
Terminated NCT04102163 - Health-Related Quality of Life in Crohn's Disease Participants With Complex Perianal Fistula Before and After Treatment
Terminated NCT02550860 - Influence of Fish Oil Based Intravenous Fat Emulsions on the Epidermal Barrier Function Phase 3
Recruiting NCT02044952 - Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission Phase 2/Phase 3
Completed NCT02227602 - Anti-Inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel Disease N/A
Active, not recruiting NCT01028898 - Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome N/A
Completed NCT00398203 - Safety and Efficacy of Using NaviAid™ BGE Device (Balloon Guided Endoscopy) For Endoscopic Diagnosis and Treatment N/A